7 Dividend Stocks to Buy on the Dip
With the stock market still volatile and in a bottoming process, it’s a good time to find dividend stocks to buy on the dip. As the old saying goes, dividend stocks “pay you to wait.” In other words, even if the market sinks, forcing the lion’s share of equities to decline, stocks with dividends limit their owners’ losses and increase the overall profits that they will generate after the market has turned around. And given the market’s steep, largely all-encompassing selloff this year, plenty of high-quality dividend stocks have quite high yields and very low valuations. 7 Nasdaq Stocks to Buy on the Dip By “high-quality dividend stocks,” I mean that these names have been reporting strong financial results and have solid businesses with powerful, long-term catalysts. GSK GSK $42.48 BX Blackstone $94.37 BBY Best Buy $71.94 BEP Brookfield Renewable Partners $36.40 D Dominion $79.26 JPM JPMorgan Chase $114.27 MCD McDonald’s $258.86 GSK (GSK) Source: Willy Barton | Shutterstock.com There’s a very good chance that GSK (NYSE: GSK ) has a blockbuster cancer drug in the making.
7 Dividend Stocks to Buy on the Dip
With the stock market still volatile and in a bottoming process, it’s a good time to find dividend stocks to buy on the dip. As the old saying goes, dividend stocks “pay you to wait.” In other words, even if the market sinks, forcing the lion’s share of equities to decline, stocks with dividends limit their owners’ losses and increase the overall profits that they will generate after the market has turned around. And given the market’s steep, largely all-encompassing selloff this year, plenty of high-quality dividend stocks have quite high yields and very low valuations. 7 Nasdaq Stocks to Buy on the Dip By “high-quality dividend stocks,” I mean that these names have been reporting strong financial results and have solid businesses with powerful, long-term catalysts. GSK GSK $42.48 BX Blackstone $94.37 BBY Best Buy $71.94 BEP Brookfield Renewable Partners $36.40 D Dominion $79.26 JPM JPMorgan Chase $114.27 MCD McDonald’s $258.86 GSK (GSK) Source: Willy Barton | Shutterstock.com There’s a very good chance that GSK (NYSE: GSK ) has a blockbuster cancer drug in the making.